Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On March 15, 2021, the Board of Directors of Wize Pharma, Inc. (the "Company") voted to approve a Certificate of Amendment of Certificate of Incorporation of Wize Pharma, Inc. (the "Charter Amendment") to change the Company's name from Wize Pharma, Inc. to Mawson Infrastructure Group Inc., pursuant to Section 242 of the General Corporation Law of the State of Delaware, which does not require a meeting or vote of stockholders to adopt an amendment that effects only a change of corporate name. The Charter Amendment was filed with the Secretary of State of Delaware, and both the Charter Amendment and change of name to Mawson Infrastructure Group Inc., became effective on March 17, 2021.

The description of the Charter Amendment is only a summary and is qualified in its entirety by the full text of such document which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated by reference.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits.



Exhibit No.   Description
3.1             Certificate of Amendment of Certificate of Incorporation of Wize
              Pharma, Inc.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

The Company cautions that statements in this report that are not a description of historical fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words referencing future events or circumstances such as "expect," "intend," "plan," "anticipate," "believe," and "will," among others. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon the Company's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" included in the Company's Annual Report on Form 10-K filed with the SEC on March 1, 2021, and in other filings that the Company has made and may make with the SEC in the future. One should not place undue reliance on these forward-looking statements, which speak only as of the date on which they were made. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as may be required by law.


                                       1

© Edgar Online, source Glimpses